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Severe acute respiratory syndrome has spread quickly throughout the world and was
declared a pandemic by the World Health Organization (WHO). The pathogenic agent is
a new coronavirus (SARS-CoV-2) that infects pulmonary cells with great effectiveness.
In this study we focus on the codon composition for the viral protein synthesis and its
relationship with the protein synthesis of the host. Our analysis reveals that SARS-CoV-2
preferred codons have poor representation of G or C nucleotides in the third position,
a characteristic which could result in an unbalance in the tRNAs pools of the infected
cells with serious implications in host protein synthesis. By integrating this observation
with proteomic data from infected cells, we observe a reduced translation rate of host
proteins associated with highly expressed genes and that they share the codon usage
bias of the virus. The functional analysis of these genes suggests that this mechanism of
epistasis can contribute to understanding how this virus evades the immune response
and the etiology of some deleterious collateral effect as a result of the viral replication. In
this manner, our finding contributes to the understanding of the SARS-CoV-2 pathogeny
and could be useful for the design of a vaccine based on the live attenuated strategy.
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1. INTRODUCTION
The new SARS-CoV-2 coronavirus is the causative agent of the current pandemic of COVID-19.
This highly pathogenic virus has quickly become the latest threat to modern life. From the end of
2019 and up to the redaction of this paper, this virus has infected over 17 million people, leading to
mild symptoms of fever and to lung function reduction, severe acute respiratory syndrome (SARS),
and even death. The current global death toll stands at 670,000; however, we are still far away from
determining the final mortality figure. In the absence of vaccines or effective antiviral treatments
against SARS-CoV-2, it is important to understand how this virus appropriates the host translation
apparatus and subverts the immune defenses of infected cells. This can be the first step in the
development of novel therapeutics.
As intracellular parasites, virus replication depends on the translational machinery of their
cellular hosts to translate viral transcripts. Thus, virus replication requires ribosomes, tRNA, and
translation factors from the cell host. On the other hand, codon usage bias is a feature of natural
selection and affects the genomes of all domains of life. It is known that more frequently used
codons are used for coding highly abundant proteins (Pan et al., 1998; Dana and Tuller, 2014; Quax
et al., 2015; Diambra, 2017). Virus genomes also have preferences in the codon usage, but, in this
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case, the bias is constrained by the host translational machinery
(Shackelton et al., 2006). The effects of codon composition of
a transcript on its translation have been reported in literature
(Gingold and Pilpel, 2011; Plotkin and Kudla, 2011; Shah and
Gilchrist, 2011; McCarthy et al., 2017) and is considered an
important determinant of gene expression (Zhou et al., 2009;
Tuller et al., 2010a,b). However, the codon usage of a gene can
also affect the translation of other genes (Frumkin et al., 2018).
In fact, the virus replication demands not only ribosomes but
also a lot tRNA resources for the codons highest in demand
(Chen et al., 2020). The consumption of specific tRNAs for the
virus replication could thus be an alternative to controlling host
protein synthesis machinery as well as generating deleterious
collateral effects on the function of the host cells. Recent evidence
supports the idea that high codon usage similarity between virus
and host can lead to a deleterious effect on the host (Chen
et al., 2020). Furthermore, Chen et al. (2020) have shown that
codon composition of highly expressed viral genes regulates the
tRNA availability, affecting the decoding time of codons in the
infected cells. In this manner the viral infection can convert
abundant codons into scarce codons, reshaping the human codon
optimality pattern. In this sense, it has been proposed that
dysregulation of the tRNA pool can lead to disease (Dhindsa
et al., 2020). In fact, there is growing evidence supporting that
synonymous variations in a coding sequence can affect its folding
and/or resulting expression level (Tsai et al., 2008; Hunt et al.,
2014; Buhr et al., 2016; Kirchner et al., 2017; von Herrmann et al.,
2018; Dhindsa et al., 2020; Kim et al., 2020).
It is known that coronavirus genomes are poor in GC content
(∼ 40%) and that there exist a preferential use of A-ended or U-
ended codons in these genomes (Gu et al., 2004; Kandeel et al.,
2020). The last bias is usually characterized in the literature as
the GC3 content. Indeed, the analysis performed by Gu et al.
(2004) suggests that this compositional constraint is a major
determinant to synonymous codon usage. Here, we study recent
proteomic data from SARS-CoV-2 infected cells (Bojkova et al.,
2020) from a novel point of view. By considering the codon
usage of the virus ORFeome, we characterize a set of genes whose
expression could be affected by the massive demand of the tRNA
which implies the virus replication. We find that those host genes
encoding proteins with similar codons to the virus ORFeome
have a lower translational rate. Extrapolating this finding to
highly expressed genes in lung, we find a small set of genes that
can be downregulated. These genes are involved in translation,
immune systems, and cell calcification, to name a few, and their
roles in the SARS-CoV-2 cell pathogenesis should be the target of
further studies.
2. MATERIALS AND METHODS
The coding sequences associated with the genome of SARS-CoV
and SARS-CoV-2 were obtained from the NCBI (NC_004718.3
and NC_045512.2, respectively). Highly expressed genes in
the lung and arterial tissues were retrieved from the GTEx
portal (gtexportal.org). Proteomic and translatomic data from
infected CACO-2 cells were retrieved from Supplementary
Material of Bojkova et al. (2020), which are publicly available
(ProteomeXchange repository, ID = PXD017710). These data
contain protein levels from 6,381 proteins and translational
rate from 2,715 proteins, and the proteomic information is
consequently not available for many proteins.
Given the coding sequence s, we compute the codon usage
frequency as fs(c) =
Nc
Ls
, where Ls is total number of codons
in the sequence s, and Nc is the number of times that codon
c is present in s. In a similar manner, we define codon usage




is the total number of codons in the ORFome, and Nc is the
number of occurrences observed codon c in the ORFome. Thus,
fs(c) and fO(c) are vector of 64 elements. To compute the CCorr of
a given sequence s with viral ORFome, we consider the Pearson’s


























We study the codon composition of two complete coronavirus
genomes by measuring the percentage of G and C nucleotides
at the wobble position of the codons (GC3 content). Figure 1A
depicts the GC3 content of each annotated coding sequence
of the SARS-CoV and SARS-CoV-2. This analysis reveals that,
in agreement with Gu et al. (2004) and Kandeel et al. (2020),
codons preferentially used by these viruses are associated with
a lower GC3 content than that expected from the random use
of nucleotides. In particular, the ORFs corresponding to the
proteins ORF1ab, ORF1a, surface, ORF6, ORF7a, and ORF8
exhibit a very low content of GC3. Specifically, the last two
proteins are highly expressed at 10 h post-infection (PI), as can
be seen in Figure 1B.
As was highlighted previously, this high expression of viral
proteins could lead to an imbalance in the tRNA pool needed
for the normal synthesis of the proteins of the host cell. Of
course, as tRNA pools depend on the cell types, the postulated
imbalance could be a tissue-dependent feature. To check this
hypothesis, we make use of the recently available data about the
proteome profile and translational rate in SARS-CoV-2-infected
cells (Bojkova et al., 2020). In this study, a CACO-2 cell line was
infected with SARS-CoV-2 and mocked, and the last one was
used as the control. From this proteome, we selected the coding
sequences corresponding to the 100 most abundant proteins in
the mock infected cells at 10 h PI. We then computed the codon
correlation (CCorr) between the codon usage of each one of
these sequences and the codon usage of all coding sequences in
SARS-CoV-2. Figure 2 depicts a scatter plot of the translational
rate of these genes from SARS-CoV-2-infected cells vs. the
corresponding CCorr (red dots). The black line is the adjusted
linear model, which shows a significant and negative correlation
between the translation rate and the codon composition of
each sequence. This means that the translational rate of coding
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FIGURE 1 | SARS-CoV-2 ORFome have lower content of GC3. (A) Bar chart comparing the G and C nucleotides on the third nucleotide (GC3) at every codon in the
ORFeome of SARS-CoV and SARS-CoV-2. (B) Bar chart showing the proteins level of nine viral proteins at 10 h post-infection (data obtained from Bojkova et al.,
2020). The GC3 content for each viral ORF is showed in the corresponding bar.
FIGURE 2 | The translational rate of genes with high CCorr in
SARS-CoV-2-infected cells is lower than the mock-infected cells. Scatter plot
showing negative correlation between translational rate of the 100 most
expressed proteins in SARS-CoV-2 infected CACO-2 cells vs. virus
codon usage.
sequence in SARS-CoV-2-infected cells is lower than in mock-
infected cells. Although the correlation (ρ = −0.26) with codon
composition is not high, reflecting the fact that other factors
could be regulating the translation rate, it is significant at a value
of 0.05 (p-value= 0.024 < 0.05).
This analysis suggests then that the codon composition
of highly expressed host-genes is a determinant of its own
translation rate and that viral replication induces a particular
case of epistasis, which could affect host cell proteostasis.
Consequently, we find it relevant to extrapolate this phenomenon
to cells affected by SARS-CoV-2. In this sense, the ACE2 receptor
has been identified as the SARS-CoV-2 cell entry. Even though
ACE2 transcript is present in almost all organs, the surface
expression of ACE2 protein is present in lung alveolar epithelial
cells and arterial and venous endothelial cells (Hamming et al.,
2004). For that reason, we elected to analyze the most expressed
genes in lung and arterial tissues extracted from the GTEx
database, two main targets of the SARS-CoV-2 infection. To this
end, we select the 100 most expressed genes in these tissues and
compute the CCorr for each sequence. Figure 3A shows that
the codon composition profile of the most expressed genes from
both lung and CACO-2 cells types are different, it is evident that
the lung cells share fewer codons in common with the SARS-
CoV-2 than the CACO-2 cells. On the other hand, the codon
composition profile of the highly expressed genes in arterial
tissue are quite similar to the genes associated with the lung
(Figure 3B). In fact, they share 60% of these highly expressed
genes (Figure 3C). Consequently, the tRNAs pool used for the
virus could be scarcer both in lung and arterial cells than in the
CACO-2 cells.
We search for those genes, highly expressed in the lung
tissue, which could be affected by the depletion of the tRNAs
consumed by virus replication. They are those whose codon
composition is similar to SARS-CoV-2 (CCorr > 0.25); these are
listed in Table 1. Before analyzing these 27 genes of interest, we
compared the translation rate of these genes with the translation
rate associated with highly expressed genes, but which differs
in their codon usage bias (CCorr < −0.075). In this sense,
we used the Mann-Whitney U test for median differences of
independent samples to analyze the difference in translational
rate between these two groups of genes. This test identified
significant differences between these groups (p-value = 0.0007),
as it can be seen in Figure 3D. We want to remark that, since
there is still no available data on translational rate from lung
cells, the last analysis was performed by using translational rate
data available from CACO-2 cells, although we know that this
data would be underestimating the difference between these two
groups of genes.
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FIGURE 3 | High codon correlation between SARS-CoV-2 and lung cells is associated with a translational rate decay over specific transcripts. (A) Frequency
distribution of CCorr on the 100 highest expressed genes in lung cells and CACO-2 cells. (B) Comparison between the CCorr frequency distributions obtained from
the 100 highest expressed genes in lung and arterial tissues. (C) The tissues of the lungs and arteries share most of the highly expressed genes. (D) Histogram of the
translational rate of 100 highest expressed genes in lung cells. Transcripts with high and low codon correlation (CCorr) with SARS-CoV-2 are highlighted.
Furthermore, we performed a GO term enrichment analysis
over the 27 genes listed in Table 1; their translation rates
are decreased by means of the Enrichr online software (Chen
et al., 2013). Figure 4 illustrates the main enrichment pathways.
This analysis reveals that codon usage could promote extensive
changes in the translation machinery of the host in agreement
with previous report in CACO-2 cells (Bojkova et al., 2020).
It is known that when canonical translation is impaired, as
part of the host defense program, specific 40S ribosomal
subunits are needed to support uncapped viral mRNA translation
(Kwan and Thompson, 2019).
Our list of genes from lung is enriched with several ribosomal
proteins that constitute both 40S (RPS6, RPS3A, RPS7, RPSA,
RPS25, RPS13, RPS12, and RPS27A) and 60S (RPL4, RPL5,
RPL21, RPLP1, RPL34, RPL9, RPL24, and RPL17) ribosomal
subunits. Many of them also appear in the set of genes derived
from arterial tissue. All of them belong to the nonsense-
mediated decay pathway that control the mRNAs with abnormal
termination. The termination codon can be recognized if the 3′
untranslated region is short or if it does not have an exon junction
complex downstream of the termination codon (Nicholson et al.,
2010). These genes are also part of the process of SRP-dependent
co-translational protein destined for the endoplasmic reticulum.
It is known that these proteins are involved in translation
particularly the gene EEF1A1, an isoform of the alpha subunit
of the elongation factor-1 expressed in lungs and arteries, which
is responsible for the GTP-dependent binding of aminoacyl-
tRNA to the ribosome. Beyond its function in translation,
EEF1A1 takes part in the innate immune system by activating
directly the transcription of IFN-gamma (Maruyama et al., 2007).
IFN-gamma activates immune cells, such as macrophages and
natural killer cells, and stimulates the major histocompatibility
complex (MHC) II-dependent presentation of antigens to the
immune system (Schroder et al., 2004). This process could
be downregulated due to a decrease in the translation rate of
EEF1A1. Furthermore, B2M, another gene in the list of decreased
translational rate, encodes one of the proteins that conform
MHC class I found on the cell surface of all nucleated cells
(Bernier, 1980). Together with TXNIP, RPS3A, and RPS27A, it is
involved in the antigen processing and presentation. Moreover,
this gene, along with S100A11, HSP90AB1, and also EEF1A1,
regulates the exocytosis of granules containing inflammatory
mediators in neutrophils (Lee et al., 2005). All these genes,
with the exception of TXNIP and S100A11, are also highly
expressed in the arterial tissue. We highlight the presence in our
analysis of the HSP90AB1, a known chaperone that facilitates the
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TABLE 1 | Set of most expressed genes in lung (GTEx) and positive correlation
with virus codon usage.
Gene name Codon corr T. rate 6 h T. rate 10 h
RPS3A 0.582 0.686 0.980
RPL5 0.559 0.585 0.271
RPL9 0.546 0.723 0.738
SPARCL1 0.536 NA NA
EEF1A1 0.531 0.948 0.627
RPS12 0.443 0.155 0.649
RPL17 0.438 NA 0.372
TPT1 0.415 1.048 0.981
RPL21 0.411 NA NA
RPS6 0.398 1.206 0.590
RPL34 0.376 0.981 0.727
RPS13 0.372 1.386 0.209
RPL4 0.370 0.919 0.799
RPS27A 0.365 NA NA
RPSA 0.352 0.902 0.643
SAT1 0.350 NA NA
A2M 0.340 NA NA
TXNIP 0.317 NA NA
RPS25 0.315 0.728 0.753
FN1 0.308 NA NA
RPL24 0.306 0.576 0.890
RPLP1 0.303 NA NA
RPS7 0.297 0.965 1.036
HSP90AB1 0.296 0.989 0.738
B2M 0.277 0.926 0.825
S100A11 0.273 1.620 0.520
MGP 0.272 NA NA
col 1: gene name, col 2: CCorr, cols 3 and 4: translational rate, infected CACO-2 cells,
measured at 6 and 10 h PI, respectively. Translational rates are relative to mock cells.
maturation of a wide range of proteins and its attenuation has
been related to idiopathic pulmonary fibrosis and cystic fibrosis
(Haase and Fitze, 2015; Wang and Ni, 2016). Our analysis also
shows a translation decrease in A2M, a plasmatic protein highly
expressed in lung and artery that inhibits a broad spectrum of
proteases, including trypsin, thrombin, and collagenase (Cater
et al., 2019). A recent study confirms our prediction, A2M level
in sera from COVID-19 patients is significantly lower than in
healthy subjects (Shen et al., 2020). Furthermore, A2M has a
key role in regulating inflammatory processes because is able
to bind to proinflammatory ligands (Feige et al., 1996). This is
particularly relevant in the context of the COVID-19-derived
cytokine storm.
In addition, we have also identified two genes (SAT1 and
MGP) belonging to the pathway of endothelial cell calcification
regulated by NOTCH1 (White et al., 2015). This finding acquires
special relevance in the context of the acute lung injury (ALI)
observed in many infected patients (Huang et al., 2020). The first
gene SAT1 catalyzes the acetylation of polyamines (spermidine
and spermine) and carries it out of the cell. The polyamine
excess is a prominent source of oxidative stress that can increase
inflammatory response (Hussain et al., 2017). Polyamines have
also been connected with the immune system (Pérez-Cano et al.,
2003). On the other hand, the MGP gene encodes the matrix gla
protein, which is also highly expressed in all vasculatures. Recent
studies suggest that MGP downregulates the tissue calcification
by sequestering bone morphogenetic proteins (White et al.,
2015). Mutations in this gene cause Keutel syndrome, which
is characterized by peripheral pulmonary stenosis, abnormal
cartilage calcification, and skin rashes (Munroe et al., 1999).
Another interesting protein predicted to be downregulated
during the infection in lung and arterial tissues is SPARC-like
1 (SPARCL-1), also known as Hevin, commonly associated with
regulation of cell migration and modulation of extracellular
matrix proteins (Girard and Springer, 1996), and it has been
shown to be involved in lymphocyte transendothelial migration
through high endothelial venules (Girard and Springer, 1995).
In this context, it is important to mention that clinical studies
over patients that suffer several cases of COVID-19 document
a dysregulation of immune response related particularly to a
lower lymphocytes count (Huang et al., 2020). In addition, our
analysis reveals a translational rate decay of fibronectin (FN1), a
master organizer of extracellular matrices that mediates cellular
interactions playing important roles in cell adhesion, hemostasis,
and thrombosis (Pankov and Yamada, 2002;Wang and Ni, 2016).
This prediction is in agreement with previous data showing
that cells infected with SARS-CoV undergo downregulation in
fibronectin expression (Surjit et al., 2004).
4. DISCUSSION
The viral infection of human cells triggers an ensemble of
host processes based on the interferons that interfere with
viral replication. These processes have co-evolved with the
viral response to the host defense, and the virus counteracts
these processes through a diversity of immuno-modulatory
mechanisms. For example, NS1 protein plays a central role in
the influenza infection by suppressing the host IFNs response.
Recent results suggest that NS1 protein can hamper the host
gene expression at the translational level by obstructing the
mRNA entrance tunnel of ribosomes (Thoms et al., 2020).
Furthermore, the N protein of porcine reproductive and
respiratory syndrome virus impairs the IFN transcription by
acting over the TXK, which together with the EEF1A1 and
PARP1 form the trimolecular complex that binds to the IFN-
γ gene promoter (Maruyama et al., 2007; Kenney and Meng,
2015). Hemagglutinin of IAVs has been shown to facilitate
IFNAR ubiquitination and degradation, reducing the levels of
IFNAR, and thus suppressing the expression of IFN-stimulated
antiviral proteins (Xia et al., 2016). These examples illustrate
the action of viral dedicated factors that downregulate the
transcription of IFNs. Up to the present, no dedicated factor
with analog function has been identified in SARS-CoV and
SARS-CoV-2. However, a recent report found a significant
lack of IFN type I and III at the transcriptional level in
human alveolar adenocarcinoma cells (Blanco-Melo et al., 2020).
On the other hand, a marked upregulation of inflammatory
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FIGURE 4 | SARS-CoV-2 codon usage may have an impact on host translational machinery. GO enrichment analysis performed over genes of interest. The most
enriched biological processes and molecular functions are highlighted. Both size and color shade of bars represent the level of significance.
mediators at the protein level (CXCL10, CCL2, IFN-α, and
γ ) has been observed in patients with SARS-CoV without
a significant amount of specific antibodies (Cameron et al.,
2007). Several cases of absence of protective immunity due
to previous infection seem to indicate a similar landscape for
COVID-19. Until now, the manner in which some patients
fail to develop adaptive immunity is yet to be elucidated. As
mentioned in the Results section, the decreased translation of
B2M could be related to this last observation since is a crucial
factor for the stable presentation of antigens derived from virus
or tumor proteins; these antigens are recognized by cytotoxic
T cells that eventually eliminate the target cell stimulating
apoptosis to prevent systemic dissemination of the disease
(Hulpke and Tampé, 2013).
MGP is also expressed at high levels in heart, kidney,
and lung which is particularly interesting in the context of
several comorbidities and collateral effects observed in the
COVID-19 patients (Nikolich-Zugich et al., 2020). For example,
skin rashes were recently reported as a new symptom of
COVID-19 and the authors postulate that recognizing rashes is
important to identify new and earlier COVID-19, cases (Bataille
et al., 2020). In this context, we highlight that permanent
skin rashes were reported as a characteristic of the Keutel
syndrome, and mutations in the MGP gene were reported
as a crucial factor in this syndrome (Munroe et al., 1999;
Khosroshahi et al., 2014). In thismanner, our results are related to
these observations.
Summing up, if the depletion of a selected set of tRNA,
induced by virus replication, affects the expression level or the
co-translation folding of these proteins, one could expect the
emergence of several systemic disorders.
5. CONCLUSION
Codon usage bias is thought to have significant effects on
translation rate, where rare codons are assumed to be translated
more slowly than common codons (Piovesan et al., 2013). It is
assumed that rare and common codons are defined by usage
rates of highly expressed genes. However, whether the codon
composition of viral ORFome can affect the translation rate
of host genes has not been thoroughly explored yet. Here,
we have shown that the synthesis of the proteins associated
with highly expressed genes, and with similar codon usage
to the one of the virus, appears to be downregulated. This
finding is in agreement with recent observations in totivirus-
infected yeast (Chen et al., 2020). Following this idea, we
determined which genes in lung could be affected by the
viral replication. A functional analysis of these genes reveals
that they could be related to collateral effects observed in
COVID-19 patients (Huang et al., 2020). Further studies are
mandatory to corroborate or discard the putative relationship
established here.
One of the main obstacles in the recent development of
vaccines has been the finding of increased infectivity observed to
occur after immunizations with whole virus vaccines or complete
spike protein vaccines. This phenomenon has been observed
both in vaccines against SARS coronavirus and in respiratory
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syncytial virus. However, just as the virus regulates the translation
of the host by its codon usage, the biotechnological manipulation
of the frequency of codons could be used to design attenuated
viruses. In this sense, other vaccine strategy has been recently
assayed, focusing on altering the codon-pair usage without
affecting protein sequence. This codon deoptimization strategy
has reduced virus replication (Coleman et al., 2008; Le Nouen
et al., 2014). We believe that our results shed light on how
codon use could affect virus attenuation and would help decrease
the damaging side effect, providing an exciting opportunity for
live-attenuated vaccine development.
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